Bryan Lawlis Insider Profile

4 Followers
Bryan Lawlis, Director at BioMarin Pharmaceutical, holds 33.14K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds ― shares in Coherus Biosciences (Ticker: CHRS), holds ― shares in Spyre Therapeutics (Ticker: SYRE).
tipranks
Bryan Lawlis

Bryan Lawlis
BioMarin Pharmaceutical (BMRN)
Director

Ranked #82,902 out of 98,123 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-54.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
0.00%
0.00%
A breakdown of Bryan Lawlis's holdings

Insider Roles

BioMarin Pharmaceutical
(BMRN)
Director
Coherus Biosciences
(CHRS)
Director
Spyre Therapeutics
(SYRE)
Director
Geron
(GERN)
Director
Roles that Bryan Lawlis holds in companies

Most Profitable Insider Trade

Stock:
BioMarin Pharmaceutical
(BMRN)
Rating:Informative Sell
Date:Dec 11, 2013 - Dec 11, 2014
Return:-36.90%
The most profitable trade made by Bryan Lawlis

Bryan Lawlis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioMarin Pharmaceutical
May 24, 2023
Director
Uninformative Buy
$2.80M
Coherus Biosciences
Director
Spyre Therapeutics
Director
Geron
May 17, 2024
Director
Uninformative Buy
67.90K
$0.00
ARDMQ
Aradigm
$0.00
HGENQ
Humanigen
$0.00
List of latest transactions for each holding click on a transaction to see Bryan Lawlis's performance on stock

Bryan Lawlis insider profile FAQ

What is the percentage of profitable transactions made by Bryan Lawlis?
The percentage of profitable transactions made by Bryan Lawlis is 0%.
    What is the average return per transaction made by Bryan Lawlis?
    The average return per transaction made by Bryan Lawlis is -54.50%.
      What stocks does Bryan Lawlis hold?
      Bryan Lawlis holds: BMRN, CHRS, SYRE, GERN, ARDMQ, HGENQ stocks.
        What was Bryan Lawlis’s latest transaction?
        Bryan Lawlis latest transaction was an Uninformative Buy of ―.
          What was Bryan Lawlis's most profitable transaction?
          Bryan Lawlis’s most profitable transaction was an Informative Sell of BMRN stock on December 11, 2013. The return on the trade was -36.90%.
            What is Bryan Lawlis's role in BioMarin Pharmaceutical?
            Bryan Lawlis's role in BioMarin Pharmaceutical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.